| Attribute |
Value |
| 52 Week Change |
-0.9327103 |
| Address1 |
505 Coast Boulevard South |
| Address2 |
Suite 307 |
| All Time High |
42.95 |
| All Time Low |
1.03 |
| Ask |
0.5915 |
| Ask Size |
1 |
| Audit Risk |
8 |
| Average Analyst Rating |
1.5 - Strong Buy |
| Average Daily Volume10 Day |
76,590 |
| Average Daily Volume3 Month |
75,074 |
| Average Volume |
75,074 |
| Average Volume10Days |
76,590 |
| Beta |
1.103 |
| Bid |
0.6483 |
| Bid Size |
1 |
| Board Risk |
9 |
| Book Value |
0.897 |
| City |
La Jolla |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
9 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
1.04 |
| Current Ratio |
5.577 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
1.215 |
| Day Low |
1.04 |
| Debt To Equity |
166.878 |
| Display Name |
CalciMedica |
| Dividend Yield |
0.0 |
| Earnings Timestamp End |
1,755,288,000 |
| Earnings Timestamp Start |
1,754,942,400 |
| Ebitda |
-19,595,000 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
0.118 |
| Enterprise Value |
-2,315,576 |
| Eps Forward |
-1.63 |
| Eps Trailing Twelve Months |
-6.85 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
2.1925 |
| Fifty Day Average Change |
-1.1525002 |
| Fifty Day Average Change Percent |
-0.5256557 |
| Fifty Two Week Change Percent |
-93.27103 |
| Fifty Two Week High |
36.0 |
| Fifty Two Week High Change |
-34.96 |
| Fifty Two Week High Change Percent |
-0.97111106 |
| Fifty Two Week Low |
1.03 |
| Fifty Two Week Low Change |
0.00999999 |
| Fifty Two Week Low Change Percent |
0.009708729 |
| Fifty Two Week Range |
1.03 - 36.0 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,686,749,400,000 |
| Float Shares |
3,786,698 |
| Forward Eps |
-1.63 |
| Forward P E |
-0.6380368 |
| Free Cashflow |
-10,536,625 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
15 |
| Fullday Change |
-0.04000008 |
| Fullday Change Percent |
-3.703711 |
| Fullday Price |
1.04 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,790,812,800 |
| Gross Margins |
0.0 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.18530001 |
| Held Percent Institutions |
0.57512003 |
| Implied Shares Outstanding |
6,828,292 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Ipo Expected Date |
2,023-06-14 |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,788,134,400 |
| Last Split Factor |
1:5 |
| Long Business Summary |
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California. |
| Long Name |
CalciMedica, Inc. |
| Market |
us_market |
| Market Cap |
7,101,423 |
| Market State |
POST |
| Max Age |
86,400 |
| Message Board Id |
finmb_34235142 |
| Most Recent Quarter |
1,782,777,600 |
| Net Income To Common |
-21,240,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
12,222,642 |
| Number Of Analyst Opinions |
3 |
| Open |
1.05 |
| Operating Cashflow |
-19,106,000 |
| Operating Margins |
0.0 |
| Overall Risk |
9 |
| Payout Ratio |
0.0 |
| Phone |
858 952 5500 |
| Previous Close |
1.08 |
| Price Hint |
4 |
| Price To Book |
1.1594203 |
| Profit Margins |
0.0 |
| Quick Ratio |
5.334 |
| Quote Source Name |
Delayed Quote |
| Quote Type |
EQUITY |
| Recommendation Key |
strong_buy |
| Recommendation Mean |
1.5 |
| Region |
US |
| Regular Market Change |
-0.04000008 |
| Regular Market Change Percent |
-3.7037113 |
| Regular Market Day High |
1.215 |
| Regular Market Day Low |
1.04 |
| Regular Market Day Range |
1.04 - 1.215 |
| Regular Market Open |
1.05 |
| Regular Market Previous Close |
1.08 |
| Regular Market Price |
1.04 |
| Regular Market Time |
1,792,180,801 |
| Regular Market Volume |
13,502 |
| Return On Assets |
-0.63584 |
| Return On Equity |
-3.6570199 |
| Sand P52 Week Change |
0.16207206 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
8 |
| Shares Outstanding |
6,828,292 |
| Shares Percent Shares Out |
0.0127 |
| Shares Short |
86,433 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
127,684 |
| Short Name |
CalciMedica, Inc. |
| Short Percent Of Float |
0.0228 |
| Short Ratio |
1.04 |
| Source Interval |
15 |
| State |
CA |
| Symbol |
CALC |
| Target High Price |
75.0 |
| Target Low Price |
9.0 |
| Target Mean Price |
38.0 |
| Target Median Price |
30.0 |
| Total Cash |
18,617,000 |
| Total Cash Per Share |
2.726 |
| Total Debt |
9,200,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-6.85 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
5.5603 |
| Two Hundred Day Average Change |
-4.5203 |
| Two Hundred Day Average Change Percent |
-0.81295973 |
| Type Disp |
Equity |
| Volume |
13,502 |
| Website |
https://calcimedica.com |
| Zip |
92,037 |